Stock Comparison
AMGN vs LLY
Amgen Inc and Eli Lilly and Company side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$193.39B
$1.08T
P/E (TTM)
24.9
42.9
Forward P/E
16.1
31.1
Price/Sales
5.2
14.9
Price/Book
21.0
32.2
EV/EBITDA
14.3
28.8
Dividend Yield
2.74%
0.55%
Profitability
Net Margin
21.00%
35.00%
Operating Margin
33.80%
49.40%
Return on Equity
101.30%
107.50%
Return on Assets
8.35%
20.70%
Growth (YoY)
Revenue Growth
5.80%
55.50%
Earnings Growth
4.40%
169.90%
Price & Risk
Beta
0.4
0.5
52-Week High
$388.36
$1,215.76
52-Week Low
$264.02
$619.40
Analyst Target
$352.77
$1,222.62
Compare AMGN and LLY your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.